Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts

Blood, Vol. 110, Issue 1, 296-304, July 1, 2007
This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-{gamma} and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway
Blood Liu et al. 110: 296

Supplemental materials for: Liu et al, Vol 110, Issue 1, 296-304

Files in this Data Supplement:

  • Figure S1. B7-H1 expression in RPMI 8226 and CD138-selected cells (JPG, 42 KB) -
    (A) B7-H1 expression in RPMI 8226 cells exposed for 24 hours in IFN- (500 IU/mL), IL3 (50 ng/mL), IL4, IL6, IL7, GM-CSF, SCF, FLT3-L (all at 100 ng/mL), IGF-1 (50 ng/mL), and SDF-1 (50 ng/mL). Data represent mean and SD of 3 experiments. (B) Same as panel A, but with CD138-selected cells from primary multiple myeloma. Data represent mean and SD of 8 samples.





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020